Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

XPhyto: Is Mescaline the Next Big Mood-Modifying Medicine?

It has the potential to be the next frontier in the psychedelics renaissance, and it represents an unprecedented opportunity to innovate a notable advancement in mental health therapy. In anecdotal studies, mescaline has shown promise in treating depression, anxiety, PTSD,...
Marc Davis | April 6, 2021 |

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome

Axsome Therapeutics shares reached a new 52-week high price today after the company reported that its AXS-05 drug achieved primary endpoint in the GEMINI Phase 3 trial in Major Depressive Disorder. The firm indicated that the positive results support a New Drug Application fil...
Streetwise Reports | December 17, 2019 |

Buzz on the Bullboards: T’is the Season for hot returns, or a lump of coal?

Once the U.S. Thanksgiving is in the rear-view, the mood among North American markets dramatically shifts. Traders must now juggle holidays, gifts, and vacations on one hand, and the end of their...
Jonathon Brown | December 1, 2022 |

Buzz on the Bullboards: Top stories drawing a curtain on the final week of 2022

The market mood is still cautious amid thin holiday trading. US stocks fell for a second day, and Treasury yields rose slightly.
Shoran Devi | December 29, 2022 |

Aurora Cannabis, Canopy Growth, EXMceuticals - who will be the best turnaround story?

Cannabis shares are not in demand at the moment. About a year ago the growth potential and possibilities of the rediscovered historical medicinal plant seemed to be endless. Today it is different, there is a hangover mood. The hype back then led to a buyer's market. Investors ...
Mario Hose | February 25, 2020 |

Bayer, Siltronic, XPhyto - is it worthwhile to invest now?

Tuesday began with green lights for most listed companies in Germany. The opinions of analysts and company announcements make the stock prices - or they are driven by the mood of economic data. The Ifo Business Climate Index, for example, rose by 2.2 points to 92.6 points in...
Mario Hose | August 25, 2020 |

The Mirage Called 'Modern Monetary Theory'

I was poring over the Federal Reserve minutes from Feb. 21, and as I was rolling my eyes and looking around my den for something to throw, I was reminded of the comments from then-Fed chairman Ben Bernanke years ago when he was asked if the Fed was "monetizing debt." The ...
Streetwise Reports | February 26, 2019 |

Subliminal Capitulation

Looking back at the events of last week, the S&P 500 finally took out the October highs at 2,941 intraday, making the 2018 bear market one of the shortest on record at 93 days (Sept. 21–Dec. 24). You will recall that I wrote in early January that the action of the Santa C...
Streetwise Reports | May 8, 2019 |

Speculators remain skeptical of Veeco Instruments (VECO)

Since March 2009, Veeco Instruments Inc. ’s ( NASDAQ: VECO , Stock Forum ) steep ascent has been underlined by its 10-week and 20-week moving averages. These intermediate-term trendlines have contained all of VECO's weekly closes in the intervening months, ...
Elizabeth Harrow | October 28, 2012 |

Eurosceptics Gained Seats in the EU. Will Gold Shine Now?

More than 200 million people in 28 nations voted in the second-largest democratic elections in the world. What interesting information can we glean from their vote – which way the wind blows now? Crucially, how does it reflect on gold? Populists and Greens Gain Seats in the...
Arkadiusz Sieron | June 6, 2019 |
1 2 3 4 5 6 7 8 9 10 ...